PriceList for Deslorelin - Lasofoxifene Tartrate CAS 190791-29-8 Chiral Purity ≥99.0% Purity ≥98.0% (HPLC) API High Purity – Ruifu

Short Description:


Product Detail

Related Products

Product Tags

Related Video

Feedback (2)

It is a good way to enhance our products and solutions and repair. Our mission will be to build creative solutions to consumers with a great experience for Carfilzomib Intermediate 868540-17-4, (S)-3-Hydroxytetrahydrofuran, Darunavir Intermidate, All products come with good quality and perfect after-sales services. Market-oriented and customer-oriented are what we have been being after. Sincerely look forward to Win-Win cooperation !
PriceList for Deslorelin - Lasofoxifene Tartrate CAS 190791-29-8 Chiral Purity ≥99.0% Purity ≥98.0% (HPLC) API High Purity – Ruifu Detail:

Manufacturer Supply with High Purity and Stable Quality
Chemical Name: Lasofoxifene Tartrate 
CAS: 190791-29-8
Appearance: White to Off-White Powder
Chiral Purity: ≥99.0%   Purity: ≥98.0% (HPLC)
Lasofoxifene Tartrate (CAS: 190791-29-8) in the treatment of Postmenopausal Osteoporosis

Chemical Name Lasofoxifene Tartrate
Synonyms (5R,6S)-5,6,7,8-Tetrahydro-6-phenyl-5-[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]-2-naphthalenol Tartrate Oporia
CAS Number 190791-29-8
CAT Number RF-API20
Stock Status In Stock, Production Scale Up to Hundreds of Kilograms
Molecular Formula C28H31NO2.ClH
Molecular Weight 450.019
Brand Ruifu Chemical
Item Specifications
Appearance White to Off-White Powder 
Moisture (K.F) ≤0.50%
Heavy Metals ≤20ppm
Chiral Purity ≥99.0%
Purity / Analysis Method ≥98.0% (HPLC)
Loss on Drying ≤0.50%
Residue on Ignition ≤0.50%
Test Standard Chinese Pharmacopoeia (CP); Enterprise Standard
Usage Active Pharmaceutical Ingredient (API); Postmenopausal Osteoporosis

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

1
2

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of Lasofoxifene Tartrate (CAS: 190791-29-8) with high quality.
Lasofoxifene Tartrate is a third-generation, non-steroidal selective estrogen receptor modulator (SERM). It selectively binds to human ERalpha with an IC50 value of 1.5 nM and inhibits bone loss in ovariectomized rats. In clinical studies of postmenopausal osteoporosis, 0.5 mg/day lasofoxifene was associated with reduced risks of nonvertebral and vertebral fractures, ER-positive breast cancer, coronary heart disease, and stroke but an increased risk of venous thromboembolic events. Lasofoxifene has also been shown to act as an inverse agonist at the CB2 cannabinoid receptor, indicating its potential to be repurposed as a therapeutic for indications wherein CB2 is a target. 


Product detail pictures:

PriceList for Deslorelin - Lasofoxifene Tartrate CAS 190791-29-8 Chiral Purity ≥99.0% Purity ≥98.0% (HPLC) API High Purity  – Ruifu detail pictures


Related Product Guide:

Good quality comes to start with; service is foremost; organization is cooperation" is our enterprise philosophy which is regularly observed and pursued by our firm for PriceList for Deslorelin - Lasofoxifene Tartrate CAS 190791-29-8 Chiral Purity ≥99.0% Purity ≥98.0% (HPLC) API High Purity – Ruifu , The product will supply to all over the world, such as: Lithuania, Holland, Hongkong, The working experience in the field has helped us forged a strong relations with customers and partners both in domestic and international market. For years, our products and solutions have been exported to more than 15 countries in the world and have been widely used by customers.
  • In China, we have many partners, this company is the most satisfying to us, reliable quality and good credit, it is worth appreciation.
    5 Stars By Letitia from Philadelphia - 2017.03.07 13:42
    Good quality and fast delivery, it's very nice. Some products have a little bit problem, but the supplier replaced timely, overall, we are satisfied.
    5 Stars By Marcie Green from Brisbane - 2018.09.19 18:37
    Write your message here and send it to us